Print Page   |   Sign In   |   Register
Newsletters
Blog Home All Blogs
Search all posts for:   

 

View all (117) posts »
 

Black Swan Connection September 2019

Posted By Administration, Thursday, September 19, 2019

September 2019

                

 6,462     1,414       472         8           6


Our goal with the Black Swan Connection is to provide our subscribers, investors and financial professional compatriots outstanding investment insight that is a step above and outside of what will normally be found in mainstream financial press. To that end we have brought together seasoned, successful, and some of the brightest professionals in their respective fields to provide the articles and advice that is based on decades of practice in the field.

Black Swan Connection Newsletter Signup

 

Breaking News

It’s all about the Oil!!

Market Watch 9-17

Oil extends drop as Saudi energy minister Prince Abdulaziz sees full return of oil output by month's end

Losses for oil futures deepened on Tuesday, as Saudi Arabia's energy minister Prince Abdulaziz bin Salman said his nation's oil production will be fully back online by the end of the month, according to CNBC. His comments follow a weekend attack on Saudi oil facilities that was estimated to have cut the kingdom's daily crude production down by 5.7 million barrels a day, sparking concerns of potentially prolonged supply shortage. October West Texas Intermediate oil (clv9) was down $2.90, or 4.6%, to trade at $60 a barrel on the New York Mercantile Exchange.

Read Full Commentary

 

Feature Article

The Changing Face of Global Oil Production

By: Dave Lavigne

September 2019

As an adjunct to the independent research I have been writing since 2001, I have spent much of that period also providing a monthly article under one of my labels. Currently, I provide that article as a part of this newsletter (Stock Market Manager’s monthly “Black Swan Connection”). To be honest, it is sometimes difficult for me to settle on a topic for each monthly article. After providing such a publication each month for what is now approaching 20 years, one starts to run out of things to say. When Ifirst started writing the articles, I tried to take a more educational approach by providing some insights on issues that I thought were topical to securities analysis in general, and/or more specifically microcap investing. Those articles addressed things like “what is EBITDA and why is it important” and “what is enterprise value and how is it derived”. While I think I am reasonably versed in applicable financial topics, at some point I felt like I had touched on most of the relevant things I knew.

Read Complete Article

 

Alternative Investments

Maybe Florida real Estate should be in your Portfolio!!

Auction.com Nov-2018

Investing in real estate is definitely one of the best ways to make money. However, there are many circumstances which determine the success of your investment, and one of the most important ones is location. If you’ve spent even only a couple of months in the real estate investing business, you must have heard that location, location, location are the three most significant factors when buying a property.

For many good reasons, Florida has been one of the top places to invest in real estate in the US housing market for many years now. To begin with, Florida is the fourth most populous state in the US, and for real estate investors (and landlords) a lot of people translates into a lot of rental demand. Moreover, Florida enjoys one of the highest population growth rates nationwide, according to the US Census Bureau. The local economy is doing quite well, and the unemployment rate has been decreasing in recent years. All these factors spell out the perfect recipe for a profitable rental property to be rented out on long-term basis. Couple these with the many tourist attractions and the beautiful climate, and you end up with an ideal location for investing in short-term rentals (or vacation homes) as well.

Another piece of good news for real estate investors considering purchasing an investment property in the Sunshine State is the fact that Florida has been witnessing strong real estate development. This has helped keep average property prices in most Florida markets at a relatively reasonable level.

Everyone has a tendency to think: well all the good deals are snapped up. That couldn’t be further from the truth !!

The following is an example of a house that was damaged in a hurricane and can be had way under market if an investor has the wherewithal to go through the process of claiming the $230,000 in FEMA grants available to rebuild.

It’s an absolutely gorgeous waterfront lot in one of the most popular areas of the Gulf Coast.

Click the Link Below for more information-

845 BAY POINT DR MADEIRA BEACH, FLORIDA 33708-2316

This is being offered through:

Gemee Minkler

BRODERICK & ASSOCIATES INC

gemeem@broderickrealty.com
Ph: 479-221-0809

Please subscribe to our newsletter to get ongoing Real Estate updates:

Black Swan Connection Newsletter Signup

 

 

8-22-19 Trickle Research Initiates Research
 Cavitation Technologies, Inc. OTCQB CVAT 
12-24 Month Price Target $0.10

Company Overview

Cavitation Technologies, Inc. (“CTI”or “CTi”) is a Nevada corporation originally incorporated under the name Bio Energy, Inc. We are a process and product development firm that has developed, patented, and commercialized environmentally friendly technology-based systems that are designed to serve large, growing, global markets such as vegetable oil refining, renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions and crude oil yield improvement. Our innovative flow-through devices and systems are designed to process industrial liquids at a reduced processing time, lower operating cost, improved yield while operating in environmentally friendly manner. We have developed, patented, and commercialized our proprietary technology that can be used in multiple liquid processing applications. Our patented Nano Reactor® is the critical component of our CTi Nano Neutralization® System which has been shown to reduce operating costs and increase yields in refining vegetable oils. CTi is defined as “the process of formation of the vapor phase of a liquid when it is subjected to reduced pressures at constant ambient temperature. Thus, it is the process of boiling in a liquid as a result of pressure reduction rather than heat addition”. (http://web.mit.edu/hml/ncfmf/16CAV.pdf).We will attempt to edify that further in the Product/Technology Overview of this report, but needless to say, it is not a concept most of us are familiar with or frankly (at least in our case) even capable of fully grasping. That notion may underscore the Company’s opportunities in terms of their ability to understand and apply the phenomenon to industries where it may represent an elegant solution. The Company launched its first pilot test

Click Here for Complete Report>>

 

9-17-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Appoints Ex-Home Depot Executive Joseph Hunsberger to its Board of Directors

HICKSVILLE, NY, Sept. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of hemp-derived THC-Free Cannabidiol (CBD) Isolate products such as oils, drops/tinctures, creams, moisturizers, chews, and capsules, is pleased to announce the appointment of Joseph Hunsberger to its Board of Directors.

Read Complete Press Release

 

9-4-19 Greenridge Global Equity Research Issues Updates
Guangdong Land Holdings, Ltd. HKSE 0124


Sales Continues At All Portfolio Properties

Unit Sales Continue Across Property Portfolio.  GDL reported first half results with Revenue of HK$464.1 million, which was generated from the delivery of 4,440m2 from Laurel House, 102m2 from Baohuaxuan, and 2,186m2 of residential space and 207m2 of car parking spaces at Ruyingju.  Pre-sales of GDH City during the period was 4,991m2.  Cost of Sales was HK$344.5 million, for a Gross Profit of HK$119.6 million, or 25.8%.  SG&A was HK$80.9 million, up significantly reflecting the greater number of projects GDL owns and increased marketing activity at GDH City.  Included in the marketing activities was a well-attended project kick-off event on June 14 for prospective buyers, renters and other partners.  Net Finance Expense was HK$35.8 million and Income Tax Expense was HK$47.2 million, which was partially offset by HK$17.0 million in Other Income, most of which was from Foreign Currency Gains.  Net Loss for the period was HK$27.4 million, or 1.98 cents per share, far below our estimate as we had assumed much faster sales of the Laurel House project.

N Land Contract Amendment.  On July 4, GDL amended its foundation pit support, earth and stone works, and piling works agreement with the contractor for its Northern Land site of GDH City, which will see GDL pay an additional HK$44.9 million.  The amendment was made primarily to account for the change in policy in Shenzhen requiring off-road vehicles to be new energy vehicles, which has markedly increased to cost to transport materials.  The change will ultimately result in a six month delay from the original timeline with this contractor, however management still believes the entirety of the N Land project will be completed as scheduled.

Related Party Sale - Laurel House Units.  On September 2, GDL announced it was selling a total of seven units from the Laurel House project to a subsidiary of its ultimate parent company, Guangdong Holdings.  A total of 692.65m2 was sold for cash at an average price of RMB 70,367 per m2, which falls in line with market prices.  GDL expects to report a net profit of RMB 2,642,000 from the sale of these units.  On July 18, GDL renewed its property management agreement with Yuehai Property Management for Laurel House, which now runs through 2020

Model Update.  Changes to our model include lengthening the time to contract and deliver units at Laurel House, increasing development expenses for GDH City as noted above, and making adjustments for the depreciation of the RMB relative to the HKD.

Maintaining Rating & Reducing Target.  The model changes noted above resulted in a reduction in our DCF valuation of the Company, from HK$4.75 to HK$4.25.  However, with GDH City making progress in terms of construction timeline and partner/tenant negotiations, we continue to believe GDL’s stock is undervalued at current prices.  As such we are reiterating our Buy rating on Guangdong Land.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.

Click Here>>

 

8-2-19 Canbiola, Inc. (OTCQB:CANB)

Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

Initial 25 Units Will Target Medical Offices

HICKSVILLE, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate announced today the launch of its own Canbiola-branded CBD product dispensing machine. An initial order for the first 25 units has been placed with the installations expected to occur in August and September.

Read Complete Press Release


7-27-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Provides Update on Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, today provides an update on the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346. The clinical study commenced in March 2019 and is designed to validate the efficacy of ATB-346 in reducing pain and establish the dose for Phase 3 development. A total of 360 patients with osteoarthritis of the knee are being randomized to either placebo or one of three doses of ATB-346 administered once daily: 150 mg, 200 mg or 250 mg.

Read Complete Press Release

 

7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release

 

7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report

 

New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

https://www.quotemedia.com/

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.

 

SMM Coverage-Special Situations

Elio Motors, Inc. (ELIO) $.92 9-18-19

No news isn’t good news….

Petition for class action lawsuit
 

SHORT- Elio Motors, Inc. –ELIO Nov-2016  $11.80  Dec 17-18 price $3.15 starting to slip slide away again. (nice chance to add to short if you can get a borrow on ELIO).  Last news was almost 5 months ago from company. Still on perpetual begathon for new reservations. Still needs $300 million plus another $545,000 to cover this fine, but reality is that this car cannot be built for the price he talks about.

Nothing new in SEC Filings and no news now for 7 months- That’s NOT good news

Posted by u/snugglesdog

 

 

August-19 MODEL PORTFOLIO FOR TRICKLE RESEARCH, LLC.

 

Initiation

 

Price

Initiation

Price @

 

Stock

Symbol

Date

Allocation

Target

Cost Px.

9/16/2019

 

SRAX (Social Reality)

SRAX

Multiple

5

$15.00

$1.79

$3.00

 

Pure Cycle

PCYO

5/5/17

3

$12.00

$7.60

$11.03

 

Command Center

CCNI

9/8/17

5

$8.75

$4.44

$7.75

 

Endurance Exploration

EXPL

11/6/17

3

$0.29

$0.18

$0.06

 

Assure Holdings Corp.

ARHH

11/10/17

5

$6.00

$2.90

$1.68

 

AzurRx BioPharma

AZRZ

2/7/18

7

$10.25

$2.96

$1.21

 

Cavitation Technologies, Inc.

CVAT

8/22/19

4

$0.10

$.0325

$0.03

 

Camino Minerals, Corp

CAMZF

4/6/18

6

$0.90

$0.26

$0.095

 

Gold Resource Corp

GORO

7/30/18

5

$7.35

$6.49

$3.75

 

Summit Wirelss

WISA

9/28/18

5

$9.25

$4.30

$0.87

 

Alvoperto Energy, Ltd.

ALVOF

11/7/18

5

$1.10

$0.39

$0.52

 

SG Blocks

SGBX

2/28/19

5

$6.25

$2.84

$0.54

 

H-Source Holdings

HSCHF

4/9/19

4

$0.19

$.06

$0.031

 

Generation Next Brands

VEND

4/10/19

3

$1.10

$.59

$.42

 

 

 

Initiation

 Termination 

 

Price

Initiation

Termination

Terminated Coverage

Symbol

Date

Date

Allocation

Target

Price

Price

ID Watchdog

IDW

10/13/16

8/28/2017

4

$0.42

$0.14

$0.40

GrowGeneration

GRWG

6/20/17

12/21/17

4

$3.40

$2.00

       $3.44  

Barfresh Food Group

BRFH

 

8/20/18

1

 

$0.55

$0.53

Semler Scientific

SMLR

12/27/17

11/7/18

    4

$15.00

$8.00

$31.99

New Jersey Mining

NJMC

4-18

5/16/19

           3

$0.30

$0.12

$1.31

Petroshare

PRHR

 

9/9/19

5

 

 

 

 

For complete details and assumptions please see the assumptions and explanations document Click Here

For a review and details on 2017 performance and model portfolio assumptions  Click Here

*Please note Dave Lavigne in the principal in Trickle Research and is also the editor of the Black Swan Connection Newsletter and an ongoing contributor to SMM.

 

September 15-19

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

   

Premium

Research

News

(listing, quotes, news, research)

 

Profile

Updates

Updates

Alvopetro Energy, Ltd. (ALVOF)

 

Profile

  06/20/19

News

Antibe Therapeutics, Inc (ATBPF)

 

 Profile

11/11/18

News

AzuerRx Biopharma, Inc. (AZRX)

 

07/11/19

News

Camino Minerals Corp. (CAMZF)

 

04/06/18

News

Canbiola, Inc. (CANB)

 

Profile

 

News

Cavitation Technologies, Inc. (CVAT)

Profile

08/22/19

News

Clean Coal Technologies, Inc (CCTC)

Profile

 

News

Command Center , Inc. (CCNI)

   

11/13/18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

  03-26/19

News

FULLSHARE HOLDINGS LTD. (607) HK

 

09/07/18

News

Guangdong Land Holdings Limited (124) HK

06-06/19

News

H-Source Holdings, Ltd (HSCHF)

04/09/19         

News

Petroshare Corp. (PRHR)

 

08/23/18

 

Summit Wireless Technologies, Inc.

   

  06/04/19

News

Social Reality, Inc. (SRAX)

   

02/05/19

News

 

 

Go to ValuEngine.com

    
 

September 13th, 2019  by Paul Henneman

ValuEngine Market Valuation update for the week of September 13, 2019. Strong Buy stock pick for the week is ticker AMRN (Amarin Corp Plc). One year price target of $18.16. There has been some changes in overall sector valuations, for example Utilities sector slowly moving up the list. As always ValuEngine data is updated daily on over 5,000 stocks. Read on for full updated numbers and stock pick.

www.ValuEngine.com to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

 

VALUATION WATCH: Overvalued stocks now make up 34.58% of our stocks assigned a

valuation and 11.65% of those equities are calculated to be overvalued by 20% or more.

 

Read Full Report

 

SMM Research Subscription Service.
Black Swan Research

Subscribers will get Real Time notification as Research Reports and updates are available as well as latest press releases and news on the companies covered.

Black Swan Research coverage is a compilation of some of the best independent providers of Micro Cap Research.  The service focuses on micro-cap companies that are typically not followed by Wall Street analysts.  In addition our subscription research service includes ValuEngine research on over 5,000 stocks with stock valuations, Buy/Hold/Sell recommendations, and forecasted target prices.

 Click Here for Complete Description

See Below for current coverage and info regarding our Research providers

Trickle Research Click Here for More info>>

*Research on the following companies is available to BS Research or Trickle research subscribers only

  • Pure Cycle (PCYO)  -
  • Semler Scientific, Inc. (SMLR)
  • Gold Resource (GORO)

Greenridge Global, LLC Click Here for More Info>>

ValuEngine Click Here for More Info >>

ValuEngine.com (VE) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available.

To Subscribe Please click Here
 

 

Reg A or D 506(c)

If you have a Reg A or 506(c) offering you would like us to distribute to our database, please give us a ring or email to:
727-823-3987
cdilley@smm.global


Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.
Click Here for Details

 

The Rocky Mountain Microcap sponsored by GVC Capital and Dave Lavigne at Trickle Research LLC Conference will be held Nov 14-2019 at Coors Field in Denver.

Click Here for Details


Carl Dilley
cdilley@smm.global

 

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                                0

Direct Email     *                                                          249,000

Total                                                                           257,354

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup

ABOUT US

This post has not been tagged.

Share |
Permalink | Comments (0)
 
Community Search
Sign In